Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1982 2
1989 1
1991 1
1992 1
1995 2
1997 2
1998 5
1999 2
2000 1
2001 1
2002 2
2004 5
2005 3
2006 9
2007 3
2008 5
2009 4
2010 6
2011 1
2012 1
2014 2
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 1331390

56 results
Results by year
Filters applied: . Clear all
Page 1
Evaluation of biodegradable microspheres as vaccine adjuvant for hepatitis B surface antigen.
Nellore RV, Pande PG, Young D, Bhagat HR. Nellore RV, et al. J Parenter Sci Technol. 1992 Sep-Oct;46(5):176-80. J Parenter Sci Technol. 1992. PMID: 1331390
Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
Jaganathan KS, Singh P, Prabakaran D, Mishra V, Vyas SP. Jaganathan KS, et al. J Pharm Pharmacol. 2004 Oct;56(10):1243-50. doi: 10.1211/0022357044418. J Pharm Pharmacol. 2004. PMID: 15482638
Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
Jaganathan KS, Vyas SP. Jaganathan KS, et al. Vaccine. 2006 May 8;24(19):4201-11. doi: 10.1016/j.vaccine.2006.01.011. Epub 2006 Jan 18. Vaccine. 2006. PMID: 16446012
Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses.
Thomas C, Gupta V, Ahsan F. Thomas C, et al. Int J Pharm. 2009 Sep 8;379(1):41-50. doi: 10.1016/j.ijpharm.2009.06.006. Epub 2009 Jun 12. Int J Pharm. 2009. PMID: 19524654
Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres.
Feng L, Qi XR, Zhou XJ, Maitani Y, Wang SC, Jiang Y, Nagai T. Feng L, et al. J Control Release. 2006 May 1;112(1):35-42. doi: 10.1016/j.jconrel.2006.01.012. Epub 2006 Mar 6. J Control Release. 2006. PMID: 16516999
In vitro and in vivo evaluations of PLGA microsphere vaccine formulations containing pDNA coexpressing hepatitis B surface antigen and Interleukin-2.
Eratalay A, Coşkun-Ari FF, Oner F, Ozcengīz E. Eratalay A, et al. J Microencapsul. 2010;27(1):48-56. doi: 10.3109/02652040902937666. J Microencapsul. 2010. PMID: 19545223
Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
Gupta RK, Griffin P Jr, Rivera R, Siber GR. Gupta RK, et al. Dev Biol Stand. 1998;92:277-87. Dev Biol Stand. 1998. PMID: 9554282
Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response.
Hansen B, Belfast M, Soung G, Song L, Egan PM, Capen R, Hogenesch H, Mancinelli R, Hem SL. Hansen B, et al. Vaccine. 2009 Feb 5;27(6):888-92. doi: 10.1016/j.vaccine.2008.11.078. Epub 2008 Dec 9. Vaccine. 2009. PMID: 19071182
Polymeric lamellar substrate particles as carrier adjuvant for recombinant hepatitis B surface antigen vaccine.
Saini V, Sahoo MK, Murthy PK, Kohli D. Saini V, et al. Vaccine. 2009 Apr 14;27(17):2372-8. doi: 10.1016/j.vaccine.2009.02.023. Epub 2009 Feb 13. Vaccine. 2009. PMID: 19428853
Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
Shi L, Caulfield MJ, Chern RT, Wilson RA, Sanyal G, Volkin DB. Shi L, et al. J Pharm Sci. 2002 Apr;91(4):1019-35. doi: 10.1002/jps.10042. J Pharm Sci. 2002. PMID: 11948541
56 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page